Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H18N2O4 |
InChIKeyYYSPJNXAGUXEGN-WOJGMQOQSA-N |
CAS Registry1462969-96-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | BR | 10 Mar 2014 |